Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$19.50 -0.66 (-3.27%)
At close: Sep 22, 2026 · 4:00 PM EDT

Amneal Pharmaceuticals (AMRX) Other Non-Current Assets (2017 - 2026)

Amneal Pharmaceuticals (AMRX) posted Other Non-Current Assets of $80.7 million for Q2 2026, up 46.99% on a QoQ basis from $54.9 million in Q1 2026, and up 79.87% year-over-year from $44.8 million in Q2 2025.

Analysis

Amneal Pharmaceuticals (AMRX) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Amneal Pharmaceuticals has reported Other Non-Current Assets for 10 years, with the latest figure at $80.7 million in Q2 2026.

  • On a quarterly basis, Other Non-Current Assets rose 79.87% year-over-year to $80.7 million in Q2 2026; TTM through Jun 2026 was $80.7 million, a 79.87% increase from a year earlier, with the FY2025 full-year figure at $57.8 million, down 3.87% from the prior year.
  • Other Non-Current Assets was $80.7 million for Q2 2026 at Amneal Pharmaceuticals, up from $54.9 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $108.3 million in Q3 2022, with the low at $36.3 million in Q3 2024.
  • Average Other Non-Current Assets over 5 years is $69.4 million, with a median of $68.8 million recorded in 2022.
  • The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets jumped 454.39% in 2022, then tumbled 59.26% in 2024.
  • Over 5 years, Other Non-Current Assets stood at $103.2 million in 2022, then slumped by 46.21% to $55.5 million in 2023, then grew by 8.31% to $60.1 million in 2024, then decreased by 3.87% to $57.8 million in 2025, then jumped by 39.55% to $80.7 million in 2026.
  • The last three Other Non-Current Assets figures came in at $80.7 million (Q2 2026), $54.9 million (Q1 2026), and $57.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn 1.79 Bn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn 1.06 Bn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn 11.74 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn 80.67 Mn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn 358.00 Mn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn 11.62 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn 14.42 Mn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn 33.39 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn 666,000.00
10 NutriBand 94.45 Mn 91.03 Mn 181,874.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 80.67 Mn
Mar 31, 2026 54.88 Mn
Dec 31, 2025 57.81 Mn
Sep 30, 2025 39.46 Mn
Jun 30, 2025 44.85 Mn
Mar 31, 2025 45.42 Mn
Dec 31, 2024 60.13 Mn
Sep 30, 2024 36.27 Mn
Jun 30, 2024 77.03 Mn
Mar 31, 2024 73.75 Mn
Dec 31, 2023 55.52 Mn
Sep 30, 2023 89.04 Mn
Jun 30, 2023 93.24 Mn
Mar 31, 2023 86.43 Mn
Dec 31, 2022 103.22 Mn
Sep 30, 2022 108.26 Mn
Jun 30, 2022 79.84 Mn
Mar 31, 2022 63.94 Mn
Dec 31, 2021 20.61 Mn
Sep 30, 2021 19.53 Mn
API Access

Amneal Pharmaceuticals Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=AMRX&period=max&api_key=YOUR_API_KEY